Analyze Diet
Human cell2006; 18(3); 135-141; doi: 10.1111/j.1749-0774.2005.tb00003.x

Derivation and induction of the differentiation of animal ES cells as well as human pluripotent stem cells derived from fetal membrane.

Abstract: We succeeded in the derivation and maintenance of pluripotent embryonic stem (ES) cells from equine and bovine blastocysts. These cells expressed markers that are characteristics of mouse ES cells, namely, alkaline phosphatase, stage-specific embryonic antigen 1, STAT 3 and Oct 4. We confirmed the pluripotential ability of these cells, which were able to undergo somatic differentiation in vitro to neural progenitors and to endothelial or hematopoietic lineages. We were able to use bovine ES cells as a source of nuclei for nuclear transfer and we generated cloned cattle with a higher frequency of pregnancies to term than has been achieved with somatic cells. On the other hand, we established human fetal membrane derived stem cell lines by the colonial cloning techniques using MEMalpha culture medium containing 10 ng/ml of EGF, 10 ng/ml of LIF and 10% fetal bovine serum (FBS). These cells appeared to maintain normal karyotype in vitro and expressed markers characteristics of stem cells. Furthermore, these cells contributed to the formation of chimeric murine embryoid bodies and gave rise to all three germ layers in vitro. Results from animal ES cells and human fetal membrane derived stem cells clearly demonstrate that these cells might be used for providing different types of cells for regenerative medicine as well as used for targeted genetic manipulation of the genome.
Publication Date: 2006-10-07 PubMed ID: 17022145DOI: 10.1111/j.1749-0774.2005.tb00003.xGoogle Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper talks about the successful derivation and maintenance of pluripotent embryonic stem (ES) cells from horse and cow blastocysts and their ability to differentiate into different cell types. It also discusses the establishment of human fetal cell lines that could potentially be used for regenerative medicine or targeted genetic manipulation.

Derivation and Maintenance of Animal ES Cells

  • The researchers were successful in deriving and maintaining pluripotent embryonic stem (ES) cells from equine and bovine blastocysts, which are early-stage embryos.
  • These ES cells exhibited markers characteristic of mouse ES cells, including alkaline phosphatase, stage-specific embryonic antigen 1, STAT 3, and Oct 4.
  • The pluripotential ability of these cells was confirmed by their capacity to undergo somatic differentiation in vitro (in a lab setting) into neural progenitors and endothelial and hematopoietic lineages, meaning that they could potentially differentiate into a variety of cell types.
  • The researchers were even able to use bovine ES cells as a source of nuclei for nuclear transfer, which led to the creation of cloned cattle with a higher frequency of successful pregnancies to term than has been observed with somatic cells.

Establishment of Human Fetal Membrane Derived Stem Cell Lines

  • On the other hand, researchers constructed human fetal membrane-derived stem cell lines using colonial cloning techniques and a specific culture medium.
  • This type of stem cells also continued to maintain a normal karyotype in vitro, signifying healthy genetic makeup and stability.
  • They also expressed markers that are characteristic of stem cells, proving their stem cell nature.
  • Moreover, these cells made a contribution to chimeric murine embryoid body formation, a model system for studying early organogenesis and tissue development, and were capable of differentiating into all three primary germ layers (ectoderm, mesoderm, and endoderm) in vitro.

Implications and Applications

  • The study’s findings involving both the animal ES cells and the human fetal membrane-derived stem cells suggest that these cells could be a potential source for different cell types needed in regenerative medicine, which aims to repair or replace damaged or diseased cells, tissues, or organs.
  • Besides, they could also be used for targeted genetic manipulation of the genome, which could be critical in genetic research and therapies.

Cite This Article

APA
Saito S, Yokoyama K, Tamagawa T, Ishiwata I. (2006). Derivation and induction of the differentiation of animal ES cells as well as human pluripotent stem cells derived from fetal membrane. Hum Cell, 18(3), 135-141. https://doi.org/10.1111/j.1749-0774.2005.tb00003.x

Publication

ISSN: 0914-7470
NlmUniqueID: 8912329
Country: Japan
Language: English
Volume: 18
Issue: 3
Pages: 135-141

Researcher Affiliations

Saito, Shigeo
  • Saito Laboratory of Cell Technology, 2095-20 Kataoka, Yaita, Tochigi 329-1571, Japan. saict1@maple.ocn.ne.jp
Yokoyama, Kazunari
    Tamagawa, Tomoharu
      Ishiwata, Isamu

        MeSH Terms

        • Animals
        • Cattle
        • Cell Differentiation
        • Embryonic Stem Cells / cytology
        • Extraembryonic Membranes / cytology
        • Horses
        • Humans
        • Mice
        • Pluripotent Stem Cells / cytology
        • Regenerative Medicine

        References

        This article includes 19 references
        1. Saito S, Sawai K, Minamihashi A, Ugai H, Murata T, Yokoyama KK. Derivation, maintenance, and induction of the differentiation in vitro of equine embryonic stem cells.. Methods Mol Biol 2006;329:59-79.
          pubmed: 16845984doi: 10.1385/1-59745-037-5:59google scholar: lookup
        2. Bjornson CR, Rietze RL, Reynolds BA, Magli MC, Vescovi AL. Turning brain into blood: a hematopoietic fate adopted by adult neural stem cells in vivo.. Science 1999 Jan 22;283(5401):534-7.
          pubmed: 9915700doi: 10.1126/science.283.5401.534google scholar: lookup
        3. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor.. Nat Med 2004 Jan;10(1):55-63.
          pubmed: 14702635doi: 10.1038/nm979google scholar: lookup
        4. Saito S, Liu B, Yokoyama K. Animal embryonic stem (ES) cells: self-renewal, pluripotency, transgenesis and nuclear transfer.. Hum Cell 2004 Sep;17(3):107-15.
        5. Fuchs E, Segre JA. Stem cells: a new lease on life.. Cell 2000 Jan 7;100(1):143-55.
          pubmed: 10647939doi: 10.1016/s0092-8674(00)81691-8google scholar: lookup
        6. Clarke DL, Johansson CB, Wilbertz J, Veress B, Nilsson E, Karlström H, Lendahl U, Frisén J. Generalized potential of adult neural stem cells.. Science 2000 Jun 2;288(5471):1660-3.
          pubmed: 10834848doi: 10.1126/science.288.5471.1660google scholar: lookup
        7. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts.. Science 1998 Nov 6;282(5391):1145-7.
          pubmed: 9804556doi: 10.1126/science.282.5391.1145google scholar: lookup
        8. Reubinoff BE, Pera MF, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro.. Nat Biotechnol 2000 Apr;18(4):399-404.
          pubmed: 10748519doi: 10.1038/74447google scholar: lookup
        9. Saito S, Sawai K, Ugai H, Moriyasu S, Minamihashi A, Yamamoto Y, Hirayama H, Kageyama S, Pan J, Murata T, Kobayashi Y, Obata Y, Yokoyama KK. Generation of cloned calves and transgenic chimeric embryos from bovine embryonic stem-like cells.. Biochem Biophys Res Commun 2003 Sep 12;309(1):104-13.
          pubmed: 12943670doi: 10.1016/s0006-291x(03)01536-5google scholar: lookup
        10. Willert K, Brown JD, Danenberg E, Duncan AW, Weissman IL, Reya T, Yates JR 3rd, Nusse R. Wnt proteins are lipid-modified and can act as stem cell growth factors.. Nature 2003 May 22;423(6938):448-52.
          pubmed: 12717451doi: 10.1038/nature01611google scholar: lookup
        11. Reya T, Duncan AW, Ailles L, Domen J, Scherer DC, Willert K, Hintz L, Nusse R, Weissman IL. A role for Wnt signalling in self-renewal of haematopoietic stem cells.. Nature 2003 May 22;423(6938):409-14.
          pubmed: 12717450doi: 10.1038/nature01593google scholar: lookup
        12. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA, Verfaillie CM. Pluripotency of mesenchymal stem cells derived from adult marrow.. Nature 2002 Jul 4;418(6893):41-9.
          pubmed: 12077603doi: 10.1038/nature00870google scholar: lookup
        13. Bain G, Kitchens D, Yao M, Huettner JE, Gottlieb DI. Embryonic stem cells express neuronal properties in vitro.. Dev Biol 1995 Apr;168(2):342-57.
          pubmed: 7729574doi: 10.1006/dbio.1995.1085google scholar: lookup
        14. Lanza RP, Cibelli JB, Blackwell C, Cristofalo VJ, Francis MK, Baerlocher GM, Mak J, Schertzer M, Chavez EA, Sawyer N, Lansdorp PM, West MD. Extension of cell life-span and telomere length in animals cloned from senescent somatic cells.. Science 2000 Apr 28;288(5466):665-9.
          pubmed: 10784448doi: 10.1126/science.288.5466.665google scholar: lookup
        15. Ying QL, Nichols J, Chambers I, Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3.. Cell 2003 Oct 31;115(3):281-92.
          pubmed: 14636556doi: 10.1016/s0092-8674(03)00847-xgoogle scholar: lookup
        16. Hochedlinger K, Jaenisch R. Nuclear transplantation: lessons from frogs and mice.. Curr Opin Cell Biol 2002 Dec;14(6):741-8.
          pubmed: 12473349doi: 10.1016/s0955-0674(02)00380-0google scholar: lookup
        17. Saito S, Ugai H, Sawai K, Yamamoto Y, Minamihashi A, Kurosaka K, Kobayashi Y, Murata T, Obata Y, Yokoyama K. Isolation of embryonic stem-like cells from equine blastocysts and their differentiation in vitro.. FEBS Lett 2002 Nov 20;531(3):389-96.
          pubmed: 12435581doi: 10.1016/s0014-5793(02)03550-0google scholar: lookup
        18. Tamagawa T, Ishiwata I, Saito S. Establishment and characterization of a pluripotent stem cell line derived from human amniotic membranes and initiation of germ layers in vitro.. Hum Cell 2004 Sep;17(3):125-30.
        19. Kasinathan P, Knott JG, Wang Z, Jerry DJ, Robl JM. Production of calves from G1 fibroblasts.. Nat Biotechnol 2001 Dec;19(12):1176-8.
          pubmed: 11731789doi: 10.1038/nbt1201-1176google scholar: lookup

        Citations

        This article has been cited 6 times.
        1. Takahashi S, Ferdousi F, Zheng YW, Oda T, Isoda H. Human Amniotic Epithelial Cells as a Tool to Investigate the Effects of Cyanidin 3-O-Glucoside on Cell Differentiation.. Int J Mol Sci 2021 Apr 5;22(7).
          doi: 10.3390/ijms22073768pubmed: 33916494google scholar: lookup
        2. Gottipamula S, Sridhar KN. Large-scale Isolation, Expansion and Characterization of Human Amniotic Epithelial Cells.. Int J Stem Cells 2018 May 30;11(1):87-95.
          doi: 10.15283/ijsc18001pubmed: 29843193google scholar: lookup
        3. Alizadeh A, Dyck SM, Karimi-Abdolrezaee S. Myelin damage and repair in pathologic CNS: challenges and prospects.. Front Mol Neurosci 2015;8:35.
          doi: 10.3389/fnmol.2015.00035pubmed: 26283909google scholar: lookup
        4. Kumar R, Ahlawat SP, Sharma M, Verma OP, Sai Kumar G, Taru Sharma G. Selection of appropriate isolation method based on morphology of blastocyst for efficient derivation of buffalo embryonic stem cells.. Cytotechnology 2014 Mar;66(2):239-50.
          doi: 10.1007/s10616-013-9561-7pubmed: 23553019google scholar: lookup
        5. Baba T, Grebe R, Hasegawa T, Bhutto I, Merges C, McLeod DS, Lutty GA. Maturation of the fetal human choriocapillaris.. Invest Ophthalmol Vis Sci 2009 Jul;50(7):3503-11.
          doi: 10.1167/iovs.08-2614pubmed: 19264887google scholar: lookup
        6. Koch TG, Berg LC, Betts DH. Concepts for the clinical use of stem cells in equine medicine.. Can Vet J 2008 Oct;49(10):1009-17.
          pubmed: 19119371